Developing Erythrose to Treat Cancer

Developing Erythrose to Treat Cancer Before erythrose can be used to treat cancer patient, it must go through proper development, which includes: Further Detailed Efficacy and Toxicity Studies. (~2-4 Million) Preclinical Development. (~2-4 Million) FDA Investigational New Drug Application. (~0.2 Million) Clinical Trials I. (~2-10 Million) Clinical II. (~50-00 Million) Clinical III. (~100-500 Million) New Drug Application. Please contact us if you are interested. In general, it costs $1 billion for one drug development. I have spent my money for this project. If you decide to put your money in, you must let me know how do you want me to spent. Any money I raise and how I spent will be published. If you can help to manage fund, please also contact me.